Search for: "In Re Mdl" Results 441 - 460 of 1,536
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
12 Sep 2014, 1:41 pm
Am., Inc.), MDL No. 6:11-md-2299, No. 12-cv-000064-RFD-PJH, 2014 U.S. [read post]
11 Sep 2014, 11:31 am
The Eleventh Circuit’s recent decision in In re Engle Cases, ___ F.3d ___, 2014 WL 4435893 (11th Cir. [read post]
8 Sep 2014, 6:00 am by Jon Robinson
Judge Eduardo Robreno recently ruled that punitive damages were available to seamen in the consolidated asbestos products liability multidistrict litigation pending in the Eastern District or Pennsylvania. [read post]
29 Aug 2014, 11:14 am
Aug. 18, 2014), which is one of many cases in the various pelvic mesh MDLs currently ongoing in West Virginia. [read post]
22 Aug 2014, 9:22 am
  See also In re Yasmin & Yaz Drospirenone Marketing, Sales Practices & Products Liability Litigation, MDL No. 2100, 2014 WL 1632149, at *7 (S.D. [read post]
6 Aug 2014, 2:34 pm
   In one day, the MDL judge issued an opinion denying all five dispositive motions filed by defendants in two individual cases (In In re: DePuy Orthopaedics, Inc. [read post]
18 Jul 2014, 11:55 am
  In re Darvocet, Darvon & Propoxyphene Products Liability Litigation, 2012 WL 3842045, at *7-8 (E.D. [read post]
30 Jun 2014, 6:07 am by Colter Paulson
It’s been more than two years since we reported on the appeal in the Darvocet MDL (In re: Darvocet, Darvon and Propoxyphene Products Liability Litigation, No. 11-md-2226-DCR, MDL 2226), which involves claims against generic manufacturers of a generic equivalent of the drug Darvon. [read post]
28 Jun 2014, 12:27 pm by Scott Andrews
The federal lawsuits have been consolidated into Multi District Litigation (MDL) 2428: In Re: Fresenius Granuflo/Naturalyte Dialysate Products Liability Litigation in the United States District Court for the District of Massachusetts. [read post]
27 Jun 2014, 2:33 pm
     After "tactfully re-characteriz[ing] their failure to warn claims through the procession of this MDL," plaintiff (and plaintiffs) finally had to put up evidence to maintain a warnings claim under New York law, which is fairly standard in terms of learned intermediary, what makes a label (in)adequate, and proximate cause. [read post]
27 Jun 2014, 9:43 am
  To the extent they’re based on the continued marketing of the drugs, these claims are disguised stop selling claims preempted by Bartlett. [read post]